The trial of Fintepla in Dravet Syndrome and LGS was run by researchers at the Brno Epilepsy Centre in Czechia.
Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results